Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition.
Suwelack
Barbara
B
Department of Internal Medicine D, University of Muenster, Albert Schweitzer Strasse 33, D-48129 Münster, Germany. suwelac@uni-muenster.de
Kempkes-Koch
M
M
Kobelt
V
V
Hillebrand
U
U
Matzkies
F
F
Gerhardt
U
U
Hohage
H
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D003404:Creatinine / Q000097:blood; D004247:DNA / Q000097:blood / Q000235:genetics / Q000302:isolation & purification; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D011183:Postoperative Complications / Q000188:drug therapy; D011507:Proteinuria
D000806:Angiotensin-Converting Enzyme Inhibitors; D007166:Immunosuppressive Agents; D004247:DNA; D003404:Creatinine; D007703:Peptidyl-Dipeptidase A